Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$62.55 USD
-3.63 (-5.49%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.51 -0.04 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HIMS 62.55 -3.63(-5.49%)
Will HIMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Other News for HIMS
HIMS Stock Faces Mixed Sentiment Ahead of Earnings Report
Option traders moderately bearish in Hims and Hers Health with shares down 5.67%
Hims & Hers Health Inc (HIMS) Faces Class Action Lawsuit Over Alleged Misconduct | HIMS ...
Hims & Hers Health Earnings Preview
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?